Paola M Arbour Form 4 TENET HEALTHCARE / Paola M Arbour ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Arbour Paola M

(Last)

(First)

(Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS

75254

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP, Chief Information Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾	03/06/2023		M		2,106	A	⁽²⁾	10,674	D
Common Stock	03/06/2023		F		829⁽³⁾	D	$60.62⁽⁴⁾	9,845	D
Common Stock⁽⁵⁾	03/06/2023		M		2,838	A	⁽²⁾	12,683	D
Common Stock	03/06/2023		F		1,117⁽³⁾	D	$59.29⁽⁴⁾	11,566	D
Common Stock⁽⁶⁾	03/06/2023		M		5,396	A	⁽²⁾	16,962	D
Common Stock	03/06/2023		F		2,124⁽³⁾	D	$59.29⁽⁴⁾	14,838	D
Common Stock⁽⁷⁾	03/06/2023		M		25,854	A	⁽²⁾	40,692	D
Common Stock	03/06/2023		F		7,686⁽³⁾	D	$59.29⁽⁴⁾	33,006	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
2022 February Restricted Stock Units	⁽¹⁾	03/06/2023		M			2,106	⁽¹⁾	⁽¹⁾	Common Stock⁽⁸⁾	2,106	$0.00	4,214	D
2021 February Restricted Stock Units	⁽⁵⁾	03/06/2023		M			2,838	⁽⁵⁾	⁽⁵⁾	Common Stock⁽⁸⁾	2,838	$0.00	2,839	D
2020 February Restricted Stock Units	⁽⁶⁾	03/06/2023		M			5,396	⁽⁶⁾	⁽⁶⁾	Common Stock⁽⁸⁾	5,396	$0.00	0	D
2020 February Performance-Based Restricted Stock Units	⁽⁷⁾	03/06/2023		M			25,854	⁽⁷⁾	⁽⁷⁾	Common Stock⁽⁸⁾	25,854	$0.00	0	D

Explanation of Responses:

1. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023.

2. Restricted stock units convert into common stock on a one-for-one basis.

3. The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan.

4. Represents the closing price of the common stock of the Issuer on the vesting date.

5. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023.

6. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023.

7. On February 26, 2020, the reporting person received a target grant of 16,188 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 25,854 units. The performance-based restricted stock units settled on March 6, 2023.

8. Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock.

Remarks:

	Chad J. Wiener, as Attorney-in-Fact for Paola M. Arbour	03/07/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Paola M Arbour Form 4TENET HEALTHCARE / Paola M Arbour ownership change